Tag: Oxford Astrazeneca

A study published in the journal The Lancet on Monday showed that the protection offered by the Oxford-AstraZeneca Covid-19 vaccine, named Covishield in India, declines after three months of receiving two doses.

New Delhi: With chances of affordable Covid-19 vaccine likely to be available by February 2021, 59 per cent Indians divulged that they will not rush to take it, a survey revealed on Wednesday. The last few weeks have given hope to the world with three vaccine makers — Pfizer, Moderna and Oxford-AstraZeneca releasing their efficacy […]

New Delhi: Serum Institute of India’s (SII) COVID-19 vaccine candidate – Covishield – has been recommended by the Subject Expert Committee (SEC) which met today to examine the emergency-use authorisation (EUA) application sought by the pharmaceutical firm. With the SEC giving a green signal to Oxford-AstraZeneca’s COVID vaccine candidate, India is one step away from […]

Geneva: The World Health Organization (WHO) has decided that potential benefits of the Oxford-AstraZeneca Covid-19 vaccine outweigh known and potential risks, amid concerns over its efficacy against the virus variant found in South Africa. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) panel on Wednesday said the two-dose AstraZeneca vaccine efficacy tended to […]

London: Of the more than 18 million AstraZeneca coronavirus vaccine doses administered in Britain, only around 30 cases of blood clots were reported, British regulators have said. The new number…